This guidance provides information in response to frequently asked questions (FAQs) that the Center for Tobacco Products (CTP) is receiving from manufacturers and other interested stakeholders (you) on demonstrating the substantial equivalence (SE) of a new tobacco product. Please submit your questions regarding the guidance to askCTP@fda.hhs.gov with the subject line “SE Webinar.”